These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: In-vitro activity of four new fluoroquinolones.
    Author: García-Rodríguez JA, García Sánchez JE, García García MI, Fresnadillo MJ, Trujillano I, García Sánchez E.
    Journal: J Antimicrob Chemother; 1994 Jul; 34(1):53-64. PubMed ID: 7961215.
    Abstract:
    The in-vitro activities of four new fluoroquinolones, E-4749, E-4874, E-4884 and E-4904, were compared with that of ciprofloxacin and sparfloxacin against 1106 clinical isolates. Against majority of Enterobacteriaceae, general antibacterial activities of E-4749 (MIC90s 0.06-1 mg/L), E-4874 (MIC90s, 0.03-0.25 mg/L) and E-4884 (MIC90s 0.01-0.5 mg/L) were comparable or slightly lower than those of ciproloxacin (MIC90s 0.01-0.25 mg/L) and sparfloxacin (MIC90s 0.01-1 mg/L). The activity of E-4904 (MIC90s 0.06-2 mg/L) was lower than those of its analogues. Most of the Escherichia coli which were resistant to ciprofloxacin (MIC > or = 2 mg/L) and Serratia spp., were resistant to the new fluoroquinolones. beta-Lactamase producing strains of Moraxella catarrhalis were very susceptible to these compounds (MICs < or = 0.008 mg/L). Most of Pseudomonas aeruginosa, non-aeruginosa Pseudomonas spp., Xanthomonas maltophilia, and Acinetobacter spp. were resistant to the new quinolones (MIC90s 8- > 16 mg/L). On the contrary, these new antimicrobials were active against the majority of the Aeromonas spp. (MIC90s < or = 0.5 mg/L). E-4749, E-4874, E-4884 and E-4904 remained active (MIC90s < or = 0.25 mg/L) against Staphylococcus aureus strains susceptible to methicillin. However, its activity was two- to eight-fold lower than that of ciprofloxacin (MIC90 0.03 mg/L) and sparfloxacin (MIC90 0.06 mg/L). Against S. aureus resistant to methicillin or ciprofloxacin, activity of these new compounds and comparators agents, was very low (MIC90s 2- > 16 mg/L). Most of the strains of Enterococcus faecalis were resistant (MIC90s > 16 mg/L). The activity of E-4874, E-4904 and sparfloxacin (MIC90 1 mg/L for each one) was higher than that of the rest of the agents tested. E-4874 (MIC90 0.25 mg/L) was four-fold more active than the other antibacterials tested (MIC90 2 mg/L) against Listeria monocytogenes. No new quinolone was active against Bacteroides fragilis (MIC90s 4-16 mg/L), Bacteroides thetaiotaomicron (MIC90s 8- > 16 mg/L), and other B. fragilis group (MIC90s 16- > 16 mg/L). Ciprofloxacin (MIC90s > 16 mg/L), and sparfloxacin (MIC90s 8-16 mg/L) also were inactive. E-4874 (MIC90 4 mg/L) was the most active quinolone tested against B.fragilis.
    [Abstract] [Full Text] [Related] [New Search]